SCI Pharmtech Inc Cash Flow Reinvestment Rate
SCI Pharmtech Inc cash flow reinvestment rate. SCI Pharmtech Inc (4119) has a Cash Flow Reinvestment Rate of 0.39x as of June 2026, reinvesting NT$60.99 Million (capex NT$60.99 Million ) from operating cash flow of NT$156.75 Million. Explore SCI Pharmtech Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of SCI Pharmtech Inc (2002–2025)
Cash flow reinvestment rate of SCI Pharmtech Inc from 2002 to 2025. Historical reinvestment intensity for SCI Pharmtech Inc across 23 annual periods. Explore capital reinvestment ratio of SCI Pharmtech Inc to see what proportion of operating cash flow is directed to capital expenditures.
SCI Pharmtech Inc Cash Flow Reinvestment Rate by Year (2002–2025)
SCI Pharmtech Inc cash flow reinvestment rate by year from 2002 to 2025. Year-by-year capital reinvestment analysis for SCI Pharmtech Inc. For the full cash flow conversion analysis, see SCI Pharmtech Inc (4119) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.21x | NT$707.54 Million | NT$220.32 Million | NT$610.00 Million | ▲ +183.7% |
| 2024 | 1.13x | NT$974.05 Million | NT$860.52 Million | NT$946.64 Million | ▼ -87.1% |
| 2023 | 8.79x | NT$1.90 Billion | NT$215.77 Million | NT$1.03 Billion | ▲ +19.7% |
| 2022 | 7.34x | NT$2.18 Billion | NT$296.56 Million | NT$1.17 Billion | ▲ +103.2% |
| 2021 | 3.61x | NT$1.01 Billion | NT$280.28 Million | NT$774.98 Million | ▲ +706.1% |
| 2020 | 0.45x | NT$435.34 Million | NT$971.53 Million | NT$217.70 Million | ▲ +32.5% |
| 2019 | 0.34x | NT$267.76 Million | NT$791.60 Million | NT$204.49 Million | ▼ -21.2% |
| 2018 | 0.43x | NT$206.20 Million | NT$480.18 Million | NT$162.44 Million | ▼ -55.9% |
| 2017 | 0.97x | NT$273.96 Million | NT$281.65 Million | NT$147.39 Million | ▲ +16.8% |
| 2016 | 0.83x | NT$418.32 Million | NT$502.11 Million | NT$177.20 Million | ▲ +15.5% |
| 2015 | 0.72x | NT$478.51 Million | NT$663.24 Million | NT$217.51 Million | ▼ -44.0% |
| 2014 | 1.29x | NT$462.15 Million | NT$358.77 Million | NT$369.15 Million | ▼ -62.8% |
| 2013 | 3.46x | NT$826.27 Million | NT$238.57 Million | NT$773.01 Million | ▲ +638.2% |
| 2012 | 0.47x | NT$180.90 Million | NT$385.57 Million | NT$180.90 Million | ▼ -20.7% |
| 2011 | 0.59x | NT$147.71 Million | NT$249.55 Million | NT$147.71 Million | ▼ -31.9% |
| 2010 | 0.87x | NT$190.34 Million | NT$218.96 Million | NT$190.34 Million | ▲ +52.1% |
| 2009 | 0.57x | NT$181.13 Million | NT$316.96 Million | NT$181.13 Million | ▲ +1.5% |
| 2008 | 0.56x | NT$138.12 Million | NT$245.29 Million | NT$138.12 Million | ▼ -43.6% |
| 2007 | 1.00x | NT$167.21 Million | NT$167.53 Million | NT$167.21 Million | ▼ -18.9% |
| 2006 | 1.23x | NT$162.00 Million | NT$131.62 Million | NT$162.00 Million | ▲ +165.3% |
| 2004 | 0.46x | NT$35.55 Million | NT$76.61 Million | NT$35.55 Million | ▼ -4.3% |
| 2003 | 0.48x | NT$100.29 Million | NT$206.86 Million | NT$100.29 Million | ▲ +24.4% |
| 2002 | 0.39x | NT$41.73 Million | NT$107.12 Million | NT$41.73 Million | — |